AI & Technical question
A chart-aware CDS assistant must feel fast enough for live clinical use while staying reliable and evidence-grounded. How would you work with engineering and ML to define the system tradeoffs and product requirements around latency, retrieval quality, grounding, fallback behavior, and failure handling, and what technical or model-level changes would you prioritize first if response time improved only by reducing answer quality?
- Abridge
- AI & Technical
- Hard
Practice this question out loud. An AI interviewer asks it, follows up like a real interviewer would, and scores your answer. Type or speak.
Start a mock interview on this question · Mock interview from a job description
What this question tests
Tests reasoning about system-level tradeoffs for a latency-sensitive, safety-critical clinical AI assistant, and prioritizing under a forced quality-versus-speed choice.
How to approach it
- Define the latency bar concretely for live clinical use, for example a target response time a clinician will actually wait for during a visit, not a generic 'fast' goal.
- Define grounding requirements: every clinical claim must cite the specific chart section or note it came from, since ungrounded speed is unacceptable in this domain.
- Define fallback behavior: when retrieval confidence is low, the system should say so explicitly or defer to the clinician rather than guessing quickly.
- Work with engineering and ML to separate levers, retrieval scope, model size, and caching, and estimate each lever's latency-versus-quality tradeoff before choosing one.
- If response time only improves by cutting answer quality, reject that lever and instead prioritize caching or pre-computation of common chart summaries.
- Set a launch gate requiring both a latency threshold and a grounding-accuracy threshold, not either alone.
What a strong answer includes
- Refuses the false choice explicitly, if the only lever cuts quality, it names caching or pre-computation as the alternative path to speed.
- Ties grounding to a concrete requirement, citation of the specific chart source, not a vague 'be accurate' goal.
- Sets a dual launch gate on latency and grounding together, reflecting that neither alone is sufficient in a clinical setting.
Common mistakes
- Accepting a quality cut to hit a speed target in a safety-critical use case.
- No explicit fallback behavior defined for low-confidence retrieval.
Likely follow-up questions
- How would you communicate a fallback response to a clinician mid-visit without disrupting their workflow?
- What would you do if caching introduced staleness risk in fast-changing charts?
More ai & technical questions
- Abridge has a post-training approach that uses clinician edits, final notes, and EHR context to improve note generation. How would you define the hypotheses, stage gates, and success metrics to take it from offline research to shadow mode to a limited production launch? What evidence would be required at each step to continue, pause, or kill the effort?Abridge · AI & Technical · Hard
- For a model that turns patient-clinician conversations into structured clinical notes, what evaluation suite would you use beyond aggregate quality scores? Specify the failure modes you would prioritize, how you would segment risk by workflow or note type, and the thresholds or escalation paths you would require before declaring the model safe enough to scale.Abridge · AI & Technical · Hard
- Abridge has access to de-identified conversations, clinician edits, final signed notes, EHR context, and downstream care actions, but each signal differs in coverage, cost, bias, and clinical relevance. How would you prioritize which signals to use first for post-training, and what framework would you use to decide whether a sparse, subjective, or expensive signal is still worth operationalizing?Abridge · AI & Technical · Hard
- Abridge has a new AI-assisted clinician workflow whose model quality is improving but still imperfect. What launch criteria would you set before exposing it in live care, how would you combine offline evals, human review, and UX guardrails, and how would you phase the rollout to manage clinical and compliance risk?Abridge · AI & Technical · Hard
- Production monitoring shows a model improves average note quality but increases rare critical errors. How would you investigate whether this is a measurement artifact, a distribution shift, or a real safety regression, and how would you decide between shipping, pausing, rolling back, or narrowing scope?Abridge · AI & Technical · Hard
- Abridge explicitly uses LLM judges, rule-based evaluators, human annotation, and online monitoring. How would you decide which of these methods belongs at each stage of the eval lifecycle, and what failure modes, cost/speed tradeoffs, and confidence limits would you communicate before teams rely on them for launch decisions?Abridge · AI & Technical · Hard
More questions from Abridge
Learn the skill behind it
Chapters of the AI PM course that teach what this question tests.
- Chapter 1: Foundations: the model and the decisions it forces on you
- Chapter 8: Evals: define good and make the number defensible
- Chapter 6: Agents and agentic architecture